| Name | Title | Contact Details |
|---|
ProKidney, a pioneer in the treatment of chronic kidney disease (CKD) through innovations in cellular therapy, was founded in 2015 after a decade of research. ProKidney`s lead product candidate, REACT® (Renal Autologous Cell Therapy), is a first-of-its-kind, patented disease-modifying autologous cellular therapy with the potential to not only slow and stabilize the progression of CKD, but in some cases drive meaningful improvement in kidney function. REACT® has received Regenerative Medicine Advanced Therapy (RMAT) designation, as well as FDA and EMA guidance, supporting an immediate start to a global registrational program, which launched in the United States on schedule in January 2022. On January 18, 2022, ProKidney announced that it would become a publicly traded company via a business combination with Social Capital Suvretta Holdings Corp. III
Anacor Pharmaceuticals is a biopharmaceutical company focused on discovering, developing and commercializing novel small-molecule therapeutics derived from its boron chemistry platform. It is based in Palo Alto, California, United States.
Clemex Technologies Inc. is a Longueuil, QC-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
BluMetric is a new company built on a proud past. Its five originating operating companies, WESA, WESAtech, Envir-Eau, OEL-HydroSys, and Seprotech, are internationally known for cutting-edge work in the fields of water/wastewater treatment and professional environmental services. Our combined staff of approximately 170 scientists, engineers, industrial hygienists, environmental auditors, project managers, financial management specialists and support personnel are uniquely equipped to undertake environmental projects of any size, in any industry. Innovation, agility and client-responsive service are our hallmarks.
VNA is a New Haven, CT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.